The safety profile of semaglutide is generally favorable, though some common side effects include nausea, vomiting, diarrhea, and constipation
They can reduce gallbladder contraction and gastrointestinal motility, which could lead to cholecystitis and stomach paralysis (gastroparesis), a condition disrupting food movement from the stomach to the intestine
Semaglutide, such as Ozempic and Wegovy, is currently considered the most potent GLP-1 for both weight loss and glycemic control, Fitch said, with evidence for cardiovascular benefit in people with type 2 diabetes and obesity
Have eye or vision problems, such as cataracts or glaucoma (increased pressure in your eyes)
Are side effects worse at higher doses